https://germanhealthreview.com/article/906277872-landmark-lancet-study-demonstrates-safety-and-efficacy-of-magnetic-seizure-therapy-in-depression German Health Review en PressRelease 2026-04-17T11:14:32+00:00 Landmark Lancet Study Demonstrates Safety and Efficacy of Magnetic Seizure Therapy in Depression https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24835043-mst-device-4096x3298.png https://germanhealthreview.com/article/906257421-global-mrna-targeting-biopolymers-market-witnesses-robust-growth-as-europe-emerges-strong-with-biontech-curevac-roche German Health Review en PressRelease 2026-04-17T08:30:51+00:00 Global mRNA Targeting Biopolymers Market Witnesses Robust Growth as Europe Emerges Strong with BioNTech, CureVac & Roche https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834986-mrna-targeting-biopolymers-mark-650x343.jpeg https://germanhealthreview.com/article/906097066-global-immunoassay-market-driven-by-north-america-as-germany-emerges-with-roche-siemens-healthineers-thermo-fisher German Health Review en PressRelease 2026-04-16T13:02:34+00:00 Global Immunoassay Market Driven by North America as Germany Emerges with Roche, Siemens Healthineers & Thermo Fisher https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834272-immunoassay-market-size-1536x1024.png https://germanhealthreview.com/article/906094435-global-rare-neurological-disease-treatment-market-dominated-by-north-america-as-germany-emerges-with-bayer-ag-pfizer German Health Review en PressRelease 2026-04-16T12:08:08+00:00 Global Rare Neurological Disease Treatment Market Dominated by North America as Germany Emerges with Bayer AG & Pfizer https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834253-rare-neurological-disease-treat-1536x1024.png https://germanhealthreview.com/article/906078423-maintmaster-verzeichnet-starke-nachfrage-nach-ki-f-r-industrielle-instandhaltung-und-produktion German Health Review en PressRelease 2026-04-16T10:18:06+00:00 Maintmaster verzeichnet starke Nachfrage nach KI für industrielle Instandhaltung und Produktion https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23951193-maintmaster-manufacturing-intel-1200x628.png https://germanhealthreview.com/article/906075945-o3sigma-establishes-u-s-headquarters-appoints-leadership-team-and-achieves-top-nasa-ai-benchmark German Health Review en PressRelease 2026-04-16T10:06:25+00:00 O3sigma Establishes U.S. Headquarters, Appoints Leadership Team, and Achieves Top NASA AI Benchmark https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834110-o3sigma-3232x1796.jpeg https://germanhealthreview.com/article/906100791-beamion-lung-1-study-results-for-zongertinib-in-treatment-na-ve-patients-with-her2-mutant-advanced-nsclc-published-in-the-new-england-journal-of German Health Review en PressRelease 2026-04-16T11:00:00+00:00 Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://germanhealthreview.com/article/906080014-aicuris-receives-fda-priority-review-for-pritelivir-nda-and-presents-new-phase-3-data-at-escmid-2026 German Health Review en PressRelease 2026-04-16T09:00:00+00:00 Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026 https://ml-eu.globenewswire.com/media/67af2a5c-0ad8-4b2b-96f0-8e7f95f0b69c/small/aicuris-logo-png.png https://germanhealthreview.com/article/906059547-atoss-unterst-tzt-charit-bei-der-workforce-management-modernisierung German Health Review en PressRelease 2026-04-16T07:00:00+00:00 ATOSS unterstützt Charité bei der Workforce Management-Modernisierung https://ml.globenewswire.com/media/24d8ce1e-5bd2-4407-bc66-97e358ca533c/medium/charite-wiebke-peitz.jpg